Department of Pediatric Oncology, Hematology and Transplantology, Institute of Pediatrics, Poznan University of Medical Sciencces, Poznan, Poland.
J Pediatr Hematol Oncol. 2023 Oct 1;45(7):e917-e920. doi: 10.1097/MPH.0000000000002727. Epub 2023 Jul 24.
Constitutional mismatch repair deficiency syndrome is a genetic disorder resulting from a biallelic mutation in one of the following genes: MLH1, MSH2, MSH6, or PMS2. Individuals with constitutional mismatch repair deficiency are highly predisposed to develop both hematological and solid cancers in childhood, particularly lymphoma, brain tumors, and gastrointestinal neoplasms. We report a case of a boy diagnosed with B-cell acute lymphoblastic leukemia at the age of 3. In 2013, at the age of 6, head magnetic resonance imaging revealed hamartoma and astrocytoma lesions in the central nervous system. Two years after treatment completion, a diagnosis of precursor T-cell lymphoblastic lymphoma, accompanied by the vena cava syndrome, was established and treated accordingly. During treatment, a genetic test using Sanger sequencing was performed-a biallelic mutation in the MSH6 gene was detected. The study revealed that the mutation 17-bp c.2277-2293del. was inherited from the patient's mother. The second mutation, 5-bp c.1135_1139delAGAGA, developed inpatient de novo. At the age of 14, the diagnosis of isolated bone marrow relapse of acute lymphoblastic leukemia B-cell type was established. Due to the almost exceeded total dose of anthracyclines, the patient's treatment included blinatumomab, and subsequently, he was qualified for allogeneic hematopoietic cell transplantation. The patient remains in complete remission for 11 months after allogeneic hematopoietic stem cell transplantation under the care of the transplant center.
错配修复缺陷综合征是一种遗传疾病,由以下基因中的两个等位基因突变引起:MLH1、MSH2、MSH6 或 PMS2。错配修复缺陷个体极易在儿童时期患上血液系统和实体癌症,特别是淋巴瘤、脑肿瘤和胃肠道肿瘤。我们报告了一例 3 岁男孩被诊断为 B 细胞急性淋巴细胞白血病的病例。2013 年,他 6 岁时,头部磁共振成像显示中枢神经系统有错构瘤和星形细胞瘤病变。治疗完成两年后,诊断为伴有腔静脉综合征的前体 T 细胞淋巴母细胞淋巴瘤,并进行了相应的治疗。在治疗过程中,进行了 Sanger 测序的基因检测,发现 MSH6 基因存在双等位基因突变。研究显示,突变 17-bp c.2277-2293del 是从患者母亲那里遗传的。第二个突变,5-bp c.1135_1139delAGAGA,是在住院期间新发生的。14 岁时,诊断为急性淋巴细胞白血病 B 细胞型孤立性骨髓复发。由于蒽环类药物的总剂量几乎超标,该患者的治疗包括blinatumomab,随后他有资格进行异基因造血细胞移植。在移植中心的护理下,该患者在进行异基因造血干细胞移植后 11 个月完全缓解。